MoneyWorks4Me

Ajanta Pharma - Quaterly Results

05 May 2023 Evaluate
A fair growth of 10.87% in the revenue at Rs. 8488.60 millions was reported in the March 2023 quarter as compared to Rs. 7656.30 millions during year-ago period.Net profit declined -13.07% to Rs. 1172.10 millions from Rs. 1348.40 millions.A decline of 1812.80 millions was observed in the OP in the quarter ended March 2023 from 2155.70 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 8488.60 7656.30 10.87 34112.70 31406.40 8.62 34112.70 31406.40 8.62
Other Income 367.50 284.20 29.31 1327.50 1397.30 -5.00 1327.50 1397.30 -5.00
PBIDT 1812.80 2155.70 -15.91 8320.30 10306.20 -19.27 8320.30 10306.20 -19.27
Interest 12.10 71.80 -83.15 52.30 91.20 -42.65 52.30 91.20 -42.65
PBDT 1800.70 2083.90 -13.59 8268.00 10215.00 -19.06 8268.00 10215.00 -19.06
Depreciation 321.10 300.90 6.71 1269.50 1209.60 4.95 1269.50 1209.60 4.95
PBT 1479.60 1783.00 -17.02 6998.50 9005.40 -22.29 6998.50 9005.40 -22.29
TAX 307.50 434.60 -29.25 1411.30 1806.80 -21.89 1411.30 1806.80 -21.89
Deferred Tax -84.50 -34.90 142.12 -29.30 95.10 -130.81 -29.30 95.10 -130.81
PAT 1172.10 1348.40 -13.07 5587.20 7198.60 -22.38 5587.20 7198.60 -22.38
Equity 252.70 171.70 47.18 252.70 171.70 47.18 252.70 171.70 47.18
PBIDTM(%) 21.36 28.16 -24.15 24.39 32.82 -25.67 24.39 32.82 -25.67
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..